Tioga raises funds for Phase III of former Merck KGaA drug in D-IBS
18 February 2010
Sukaina Virji
Please Login to read the full article.
18 February 2010
Sukaina Virji
sukaina.virji@informa.com
Tioga Pharmaceuticals has raised $18 million to finance a Phase III trial of asimadoline for the treatment of patients with diarrhoea-predominant irritable bowel syndrome (D-IBS).
Tioga was set up in 2005 as a
Merck KGaA spin-out founded by investment firm Forward Ventures to pursue asimadoline,...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
